DnB Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.33M | Buy |
234,157
+4,675
| +2% | +$146K | 0.03% | 317 |
|
|
2025
Q1 | $7.7M | Buy |
229,482
+26,239
| +13% | +$880K | 0.04% | 302 |
|
|
2024
Q4 | $7.97M | Buy |
203,243
+12,620
| +7% | +$495K | 0.03% | 305 |
|
|
2024
Q3 | $7.5M | Buy |
190,623
+14,890
| +8% | +$586K | 0.03% | 313 |
|
|
2024
Q2 | $6.85M | Buy |
175,733
+49,483
| +39% | +$1.93M | 0.03% | 296 |
|
|
2024
Q1 | $5.44M | Sell |
126,250
-125
| -0.1% | -$5.38K | 0.03% | 341 |
|
|
2023
Q4 | $5.82M | Buy |
126,375
+4,605
| +4% | +$212K | 0.03% | 330 |
|
|
2023
Q3 | $4.16M | Buy |
121,770
+9,141
| +8% | +$312K | 0.02% | 385 |
|
|
2023
Q2 | $4.34M | Buy |
112,629
+13,770
| +14% | +$530K | 0.02% | 382 |
|
|
2023
Q1 | $3.54M | Buy |
98,859
+4,308
| +5% | +$154K | 0.02% | 435 |
|
|
2022
Q4 | $3.73M | Buy |
+94,551
| New | +$3.73M | 0.03% | 407 |
|